SyntekaBio, Inc. (KOSDAQ:226330)
South Korea · Delayed Price · Currency is KRW 1,528.00
+96.00 (6.70%)
At close: Aug 3, 2026
SyntekaBio Market Cap
SyntekaBio has a market cap or net worth of 37.07 billion as of August 3, 2026. Its market cap has decreased by -59.98% in one year.
Market Cap
37.07B
Enterprise Value
31.47B
Revenue
2.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,528.00
ChartMarket Cap Chart
Since December 17, 2019, SyntekaBio's market cap has decreased from 219.69B to 37.07B, a decrease of -83.13%. That is a compound annual growth rate of -23.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 37.07B | -37.63% |
| Dec 30, 2025 | 59.43B | -25.81% |
| Dec 30, 2024 | 80.11B | -63.06% |
| Dec 28, 2023 | 216.88B | 87.00% |
| Dec 29, 2022 | 115.98B | -52.00% |
| Dec 30, 2021 | 241.65B | -21.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CJ Bioscience | 44.81B |
| The Asia Business Daily | 42.96B |
| iMBC Co.,Ltd. | 36.75B |
| DEEPNOID | 36.13B |
| YBM Net | 34.80B |
| Carelabs Co.,Ltd | 33.95B |
| Daishin Information & Communications | 32.13B |
| Mr. Blue | 31.64B |